Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerosis Treatment

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis remains one of the most challenging neurological diseases facing patients and clinicians because of its progressive nature, unpredictable course and lack of a cure. The disease affects more than 2.8 million people worldwide and approximately 1 million […]

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) Is ‘One to Watch’

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) develops artificial intelligence-powered platforms focused on accelerating chemistry research and development across pharmaceutical, defense, public safety, and industrial applications. The company is working at the intersection of AI and chemistry, building tools intended to help […]

Bitcoin as a Corporate Treasury Asset: How MindWave Innovations Inc. (NYSE American: APUS) Is Redefining Institutional Yield Infrastructure 

MindWave Innovations (NYSE American: APUS) is strategically positioning itself at the forefront of a structural shift in corporate finance: the transition from static treasury holdings to intelligent, yield-generating digital asset infrastructure. As companies increasingly follow the path pioneered by MicroStrategy and newer institutional adopters, the demand for compliant, secure, and yield-optimized Bitcoin treasury systems has […]

Oncotelic Therapeutics Inc. (OTLC) Combines Nanomedicine, AI, and Robotics to Advance Precision Oncology and Rare Disease Innovation

Oncotelic Therapeutics (OTCQB: OTLC) is strategically placing itself at the nexus of precision oncology, advanced automation, and artificial intelligence. Through its PDAOAI artificial intelligence ecosystem, Deciparticle(TM) nanomedicine platform, and emerging robotics initiatives, the company is quickly building an integrated technology portfolio built to improve the way therapies are developed, manufactured, and delivered to patients suffering […]

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets Growing Need for Non-Invasive Intoxication Detection 

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. Workplace impairment testing remains an essential component of risk management across many industries, but the methods used today have changed relatively little over the past several decades. Employers continue to rely heavily on breathalyzers, saliva tests, urine screening and […]

Numa Numa Resources Inc. Committed to Advancing Bougainville Infrastructure Alongside Mining Development

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Modern mining projects are no longer judged solely by the minerals they produce. Increasingly, companies are being evaluated on the roads they build, the power systems they create and the long-term economic opportunities they leave behind. In Bougainville, Numa Numa Resources is […]

Democratizing the Space Economy: How Public Investment Vehicles Are Opening Private Orbital Opportunities

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. The commercial space economy is entering a new phase of growth. What was once dominated by government agencies is rapidly evolving into a global industry encompassing satellite communications, orbital infrastructure, artificial intelligence, robotics, energy systems, and even lunar development. With […]

Forward Industries Inc. (NASDAQ: FWDI) to Join Russell 2000(R) and 3000(R) Indexes as Part of Russell Indexes Semi-Annual Reconstitution

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced that it is set to join both the broad-market Russell 3000(R) Index and the small-cap Russell 2000(R) Index (https://ibn.fm/KcXh1).  The move is a part of Russell indexes’ semi-annual reconstitution, which is effective once the US market opens on June 29, 2026. This semi-annual reconstitution of […]

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Marks Significant Milestone with Ocean Partners UK Ltd. Definitive Gold and Silver Dore Purchase Agreement

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd. With the agreement, Ocean Partners […]

Regentis Biomaterials Ltd. (NYSE American: RGNT): Could GelrinC Become the First Widely Adopted Off-the-Shelf Regenerative Cartilage Repair Platform?

Regenerative medicine has long promised to transform patient care, but investors often become most interested when innovative science begins transitioning toward commercial adoption. Regentis Biomaterials (NYSE American: RGNT) is approaching that transition with GelrinC(R), its cartilage regeneration platform targeting a large orthopedic market where treatment alternatives continue to involve meaningful trade-offs. The opportunity is significant. […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerosis Treatment

June 8, 2026

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis remains one of the most challenging neurological diseases facing patients and clinicians because of its progressive nature, unpredictable course and lack of a cure. The disease affects more than 2.8 million people worldwide and approximately 1 million […]

Rotate your device 90° to view site.